Lingotto Investment Management’s Ginkgo Bioworks DNA Stock Holding History

Lingotto Investment Management’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-250,282	Closed	-$2.08M	–	37
2025 Q4	$2.08M	Hold	250,282	–	–	0.04%	38
2025 Q3	$3.65M	Hold	250,282	–	–	0.07%	35
2025 Q2	$2.82M	Hold	250,282	–	–	0.06%	42
2025 Q1	$1.43M	Hold	250,282	–	–	0.04%	44
2024 Q4	$2.46M	Hold	250,282	–	–	0.07%	49
2024 Q3	$2.04M	Sell	250,282 -1	-0%	-$10	0.06%	44
2024 Q2	$3.35M	Hold	250,283	–	–	0.11%	41
2024 Q1	$11.6M	Buy	250,283 +37,500	+18%	+$1.94M	0.49%	23
2023 Q4	$14.4M	Buy	212,783 +55,000	+35%	+$3.37M	0.69%	22
2023 Q3	$11.4M	Hold	157,783	–	–	0.61%	19
2023 Q2	$11.7M	Buy	+157,783	New	+$9.34M	0.76%	19

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lingotto Investment Management's DNA Position: Q1 2026 in Review

Lingotto Investment Management sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 250,282 shares — an estimated $2.08M sold.

Lingotto Investment Management first reported a position in DNA in Q2 2023 and held it in 11 quarters. The position peaked at $14.4M in Q4 2023. 175 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

Lingotto Investment Management reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
Lingotto Investment Management sold 250,282 Ginkgo Bioworks shares in Q1 2026, an estimated $2.08M.
Lingotto Investment Management first reported a position in Ginkgo Bioworks in Q2 2023 and held it in 11 quarters.
Lingotto Investment Management's Ginkgo Bioworks position peaked at $14.4M in Q4 2023.
175 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Lingotto Investment Management's 13F filing for Q1 2026, filed 14 May 2026.